LXRX vs VICI · rev $21.8M vs P/E 9.3, rev $2.08B
Lexicon Pharmaceuticals Inc (LXRX) versus VICI Properties Inc (VICI) — a side-by-side from cached financials, not a winner call.
Lexicon Pharmaceuticals Inc (LXRX) is a biotechnology company listed on US.
VICI Properties Inc (VICI) is a reit - diversified company listed on NYSE.
Latest reported LXRX revenue for 2026-06-30 was $21.8M. Net income was -$32.8M. Revenue was up 3.3% from 2026-03-31 to 2026-06-30. LXRX currently screens at market cap $327.2M.
Latest reported VICI revenue for 2026-06-30 was $2.08B. Net income was $1.40B. VICI currently screens at market cap $29.32B and trailing P/E 9.3.
LXRX currently screens at market cap $327.2M. VICI currently screens at market cap $29.32B and trailing P/E 9.3.
Not investment advice. Open the LXRX and VICI stock pages for the full models.
Not investment advice.